Pegylation Explained: What It Is & Other Drug Modifications

Pegylation is a process of attaching polyethylene glycol (PEG) molecules to a drug or therapeutic protein. This modification is done to improve the pharmacokinetic properties of the molecule, such as increasing its stability, prolonging its circulation time in the body, and reducing immunogenicity. Pegylation can enhance the therapeutic efficacy and reduce the frequency of dosing required for the drug.

Apart from pegylation, there are several other modifications that can be made to drugs or therapeutic proteins. One such modification is Fc fusion, where the Fc region of an antibody is fused to a therapeutic protein or peptide. This modification can increase the half-life of the molecule and enhance its stability.

Other modifications include glycosylation, which involves adding carbohydrate molecules to the protein, and lipidation, where lipid molecules are attached to the protein. These modifications can affect the protein's solubility, stability, and interaction with its target.

Overall, these modifications are employed to improve the pharmacological properties of drugs or therapeutic proteins, aiming to enhance their therapeutic effectiveness and patient compliance.